To elucidate whether the endometriotic cells of endometriomas synthesize transforming growth factor beta1 (TGF-beta1) and understand how it affects surrounding ovarian tissue. We collected biopsies of the cystic walls from 42 endometriomas and 29 mature teratomas and compared mRNA and protein expression of fibrosis-related factors between the cystic walls. Then we detected TGFB1 mRNA synthesis in endometriomas, and tested TGF-beta1 fibrotic effect in vitro. Moreover, we verified the expression of Smad2/3 signaling components in the endometriotic cystic wall in order to understand whether TGF-beta1/Smad signaling is involved in fibrosis formation of the tissue surrounding endometriomas. The cystic walls from endometriomas demonstrated severe adhesion to ovarian tissue and obvious fibrosis compared with the mature teratomas, which was proven by the increased mRNA expression of fibrotic markers. Additionally, TGFB1 was obviously expressed in the endometriotic cystic wall, and total TGFB1 protein was significantly higher in the cystic walls of endometriomas than mature teratomas. Interestingly, TGFB1 mRNA was confirmed to be specifically synthesized in the endometriotic loci through fluorescence in situ hybridization. Cultured endometriomas derived stromal cells showed obvious fibrosis after exposed to TGF-beta1. Furthermore, components of the TGF-beta1/Smad pathway such as Smad2, Smad3, Smad4, and their phosphorylated forms were also expressed in the same location as TGF-beta1, TGF-beta receptor1, and fibrotic factors expressed in the endometriotic cystic walls. In summary, endometriotic cells of endometriomas synthesize TGF-beta1 leading to fibrosis and adhesion to ovarian tissues, and TGF-beta1/Smad signaling pathway is involved in this pathological process. Shi et al., 2017, Vol. 97, No. 6 
Introduction
Endometriosis, defined as the presence of endometrial-like tissue outside the uterus, is a benign gynecological disorder associated with pelvic pain and infertility [1] . The prevalence of endometriosis is estimated to range from 2% to 10% for women of reproductive age [2] . In the ovary, endometriosis progression leads to bleeding and adhesions that result in endometrioma (endometriotic cyst) formation [3] . Ovarian endometriomas may be present in up to 30%-40% of patients with endometriosis [4] [5] [6] . Studies have reported that 55% of cortical samples from ovaries with endometriomas showed fibrosis and a concomitant loss of cortex-specific stromal and follicular reserves, even in endometriotic cysts less than 4 cm, loss of follicular reserve is present together with the formation of fibrosis in the cortex of the ovary [3, 7] . However, no study has adequately explained the specific pathogenic mechanism underlying how ovarian endometriomas trigger fibrosis in surrounding ovarian tissues.
Surgical intervention is strongly recommended for endometriomas because medical therapy alone is inadequate [8] . According to the ESHRE (European Society of Human Reproduction and Embryology Annual Meeting) guidelines of 2014, ovarian cystectomy is recommended in women with endometrioma larger than 3 cm for the secondary prevention of endometriosis-associated symptoms and for improving the accessibility of follicles prior to Assisted Reproductive Technology [2] . However, excision of the cystic wall is risky as damage to ovary cortex can occur during cystectomy [9, 10] . The main risks associated with surgery are the inadvertent removal or destruction of normal ovarian cortex close to the endometrioma [11, 12] , which as a consequence decrease ovarian reserve and increase the risk of infertility [13] . In these series, studies of whether cystectomy inserts ovarian damage due to endometriotic cyst, other nonhormone-dependent benign ovarian cysts such as mature teratomas, serous cyst, and mucinous cyst are usually selected as control [9, 10, 14] . Mature cystic teratoma is the most common benign ovarian cyst in women of reproductive age [15] . Despite its high prevalence, mature cystic teratomas cause simple mechanical tissue stretching and do significantly not affect ovarian reserves [16] . During our clinical laparoscopic cystectomy for benign ovarian cysts, we found it is more difficult to separate and remove the endometriomas cysts from surrounding ovarian tissue compared to mature teratomas cysts because endometriotic cyst tissues can severely adhere to the surrounding normal ovarian tissue. Therefore, we choose mature teratomas as controls and will explore the molecular pathogenesis of fibrosis and adhesion around endometriomas in this study.
Transforming growth factor β1 (TGF-β1) is widely recognized as one of the key factors that cause fibrosis in a variety of tissues including cardiac [17] , pulmonary [18] , renal [19] , and hepatic tissue [20] . The relationship between TGF-β1 and endometriosis, mainly including peritoneal endometriosis [21] and deep endometriosis [22, 23] has been widely discussed. As there are three distinct types of endometriosis: peritoneal, ovarian, and deep endometriosis, each of which is thought to have a different pathogenesis [11] . The endometriotic lesions of endometriomas are located in ovaries that are more closed to follicular anatomically, which might insert a more direct influence on women's fertility. However, studies on whether endometriomas express TGF-β1, whether it induces fibrosis in adjacent ovarian tissues and whether its downstream signaling is involved in the process has been limited. Therefore, in the effort to clarify the mechanism associated with tissue fibrosis surrounding endometriomas, we made a comparison of molecular and histologic characteristics between cystic walls of endometriomas and that of mature teratomas, and we explored the source of TGF-β1 and its contributing role in tissue fibrosis.
Materials and methods

Patient selection
The study included 71 prospectively enrolled women who underwent laparoscopic surgery, respectively, for ovarian endometriomas (n = 42) or mature teratomas (n = 29) between September 2014 and December 2015. The inclusion criteria included those with regular menstrual cycles and without previous ovarian surgery. Patients with endocrine disorders or undergoing hormonal treatment within the last 3 months were excluded. Three patients are enrolled for endometriomas derived stromal cells (EdSCs) isolation. The inclusion/exclusion criteria of patients enrolled for EdSCs isolation are consistent with the inclusion/exclusion criteria of patients who enrolled in this study and underwent laparoscopic surgery for ovarian endometriomas. The diameter of the benign ovarian cysts ranged from 10 to 97 mm as estimated by ultrasound. The patients with endometriomas ranged from 23 to 47 years and were classified as stage III or IV according to the American Society for Reproductive Medicine classification of endometriosis [24] . The women with mature ovarian teratomas, ranged from age 20 to 46 years, presented with a normal karyotype and the absence of invasiveness and metastases [25] .
The use of human surgical specimens for this study was approved by the Institutional Review Board of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University and signed informed consent was obtained from all participants before inclusion.
Surgical procedures and biopsy collection
Laparoscopic surgeries for the benign ovarian cysts were performed without complications. After cystectomy, a 1 × 1 cm 2 piece of the cystic wall of the ovarian cyst was excised using scissors under macroscopic evaluation. Each sample was divided into three parts: one for histological detection, and two for RNA and protein extraction.
Histological examination
Specimens were immediately fixed in 4% neutral buffered paraformaldehyde, dehydrated, cleared, and embedded in paraffin blocks. Histological sections were subjected to hematoxylin and eosin (HE) and Masson's trichrome staining as previously described [26] . The presence of endometriotic foci, characterized by the 
Immunohistochemistry
Immunohistochemistry (IHC) was performed as described previously [26] to detect markers of fibrosis and the expression of the main components in TGF-β1/Smad signaling pathway. Briefly, a series of 5-μm sections was incubated with the following antibodies: monoclonal rabbit antibodies against human TGFB1 ( The proper negative controls were performed with substitution of serum at the same protein concentration as the primary antibodies. Each of these slides should not show any non-specific staining (Supplemental Figure S3 ). Positive control for each primary antibody was performed according to the manufacturer's instructions with the same concentration used in these experiments. TGFB1, TGFBR1, CD10, CTGF, p-SMAD2, p-SMAD3, and SMAD2 specific expressed in positive cells' nucleus, cytoplasm, and cytomembrane. While KRT (pan), ACTA2, COL1A1, SMAD3, and SMAD4 specific expressed in positive cells' cytoplasm and cytomembrane (Supplemental Figure S5 ).
For each primary antibody staining the cystic walls of endometriomas, the percentage of positive expression coverage areas of three microscopic fields were quantified and compared with using Image J software. This quantification analysis was repeated in three samples.
Western blotting analysis
Proteins for western blotting shown in Figure 4 were extracted from the whole tissue of the cystic walls of endometriomas and mature teratomas, respectively. Proteins for western blotting shown in Figure 6 were extracted from EdSCs. Primary antibodies, including polyclonal rabbit antibodies against GAPDH (FL-335) (sc-25778; Santa Cruz Biotechnology), TGFB1 (ab125287; Abcam, Cambridge, UK), CTGF (ab125943; Abcam), matrix metalloproteinases 2 (MMP2, 0422; Cell Signaling Technology, Beverly, MA, USA), rabbit monoclonal antibodies against ACTA2 (ab32575; Abcam), and COL1A1 (ab138492; Abcam) were used at dilutions of 1:3000, 1:1000, 1:1000, 1:1000, 1:1000, and 1:1000, respectively. A Smad2/3 antibody (12744; Cell Signaling Technology) was used to assess the expression of the main components in TGF-β1/Smad pathway. A horseradish peroxidase-conjugated secondary antibody was incubated after the primary antibodies. The ECL kit (Millipore, Billerica, MA, USA) was used to develop the blots.
Fluorescence in situ hybridization of the TGFB1 locus
An oligonucleotide probe complementary to TGFB1 was purchased from Biosense Bioscience Co. (Guangzhou, China). The probe sequence was:
5 -gggttcaggtaccgcttctcggagctctgatgtgttgaagaacatatatatgctgtgtgt actctgcttgaacttgtcatagatttcgttgtgggtttccaccattagcacgcgggtgacctccttggc gtagtagtcggcctcaggctcgggctccggttctgcactctccccggccacccggtcgcgggtgc tgttgtacagggcgagcacggcctcgggcagcgggccgggcggcacctccccctgg-3 . A scrambled probe was used as a control. Serial tissue sections of ovarian endometriotic cystic walls were deparaffinized and then treated with Proteinase K mixture at 55
• C for 15 min. Then the dehydration was reached with the different concentration ethanol. After denatured at 78
• C for 5 min, dehydrated samples again and dried the samples. For the following hybridization, the probe mixture was applied to each section to proceed incubate for 16 h to 20 h at 37
• C in a humid chamber. Nuclei were stained with DAPI.
Stained samples were analyzed under a fluorescence microscope. Excitation wavelengths were 405 nm for DAPI and 488 nm for 6-FAM with emissions detected at appropriate wavelengths. Images of mRNA signals were captured using a DMI 6000B fluorescence microscope (Leica Microsystems, Wetzlar, Germany).
Statistical analysis
Continuous data are expressed as mean ± standard deviation, and categorical data are expressed as percentages. All data were assessed for distributional normality using the Shapiro-Wilk test. For continuous data, normal distribution parameters were compared using the Student t-test, while non-normal distribution parameters were compared using the Mann-Whitney U-test. Categorical variables were compared using the Pearson test. P < 0.05 was considered statistically significant. The data were analyzed using the SPSS v20.0 for Mac (SPSS Inc., Chicago, IL, USA).
Results
Macroscopic and histologic features of the cystic walls from endometriomas and mature teratomas
The clinicopathological characteristics of patients in the endometrioma and mature teratoma groups are detailed in Supplemental  Table S2 . There were no significant differences in age, BMI, or cystic diameter and severity between the two groups. Figure 1A and B showed images captured from laparoscopic surgeries for endometrioma and mature teratoma, respectively. Fibrosis was identified by filamentous green staining and/or stratified hypocellular (paint-like) staining. The cystic walls of endometriomas and mature teratomas were demonstrated by HE ( Figure 1C and D) and Masson's trichrome staining ( Figure 1E and F) , respectively. The green regions of the cystic walls of endometriomas ( Figure 1E ) demonstrated obvious fibrosis when compared with mature teratomas ( Figure 1F ).
Genetic feature of fibrosis in the cystic walls of endometriomas and mature teratomas by real-time quantitative polymerase chain reaction
To investigate the fibrotic characteristics of cystic walls, samples of specific cystic walls were taken as schematized in Supplemental Figure S1 . As detected by RT-qPCR, the relative mRNA levels of the main fibrotic markers, including COL1A1, ACTA2, CTGF, TIMP1 (tissue inhibitor of metalloproteinases 1), and MMP2
( Figure 2A -F) were significantly higher in the cystic walls of endometriomas compared with mature teratomas (data presented in Supplemental Table S3 ). Even though the relative mRNA levels of TIMP2 increased and MMP2/TIMP1 ratio decreased slightly in the cystic walls of endometriomas, they did not show a significant difference. MMP2/TIMP2 ratio increased significantly in the cystic walls of endometriomas. As the interplay and balance of MMPs and TIMPs determine the maintenance of interstitial tissue homeostasis, the net result of the MMP/TIMP imbalance favors matrix remodeling resulting in an increased degree of fibrosis in the cystic walls around endometriomas.
Examining TGFB1 expression in the cystic walls of endometriomas and mature teratomas by immunohistochemistry
To determine whether TGF-β1 was differentially expressed in the cystic walls of endometriomas compared with mature teratomas, TGFB1 IHC staining was performed. IHC staining of KRT (pan) ( Figure 3A ) and CD10 ( Figure 3B ), which are considered the gold standard for disease diagnosis, identified the endometriotic epithelium and stroma. Interestingly, TGFB1 protein expression overlapped the endometriotic cells ( Figure 3C and D) . By contrast, TGFB1 was not expressed in the cystic walls of mature teratomas, even in the epithelial cells close to the cystic cavity surface ( Figure 3E and F, black arrows). The negative control was shown in Supplemental Figure S3A -D.
Testing TGFB1 expression in the cystic walls of endometriomas and mature teratomas by western blotting
To quantitatively compare the total TGFB1 protein in the cystic walls between endometriomas and teratomas, five samples of each group were detected by western blotting analysis, respectively ( Figure 4A ). Normalized TGFB1 protein levels were significantly higher in cystic walls from ovarian endometriomas than from mature teratomas (P < 0.01; Figure 4B ).
Detecting the location of TGFB1 mRNA synthesizing in endometriomas by fluorescence in situ hybridization
To further evaluate the source where TGFB1 mRNA was specifically synthesized in endometriomas, fluorescence in situ hybridization (FISH) was performed on the cystic walls of endometriomas. Figure 5A , C, and E showed three patients with cystic walls stained positive with the TGFB1 probe; Figure 5B , D, and F showed corresponding serial sections stained with Masson's trichrome. Green signals represented the expression of TGFB1 while blue signals represented cell nuclei. TGFB1 was expressed in the endometriotic cells in all three cases. These results demonstrated that endometriotic cells specifically synthesized TGFB1.
Analyzing effects of TGFB1 on endometriomas derived stromal cells fibrosis in vitro
In this study, we isolated EdSCs from endometriomas tissue to administrate endometriosis-related functional experiments in vitro. After confirming it was endometriotic cells that synthesized TGF-β1, we evaluated the effects of TGF-β1 on EdSCs fibrosis in vitro. Through immunofluorescence, the expression of VIM was positive while KRT18 was negative in all EdSCs (Supplemental Figure S2A-F) . The results confirmed that the isolated cells were stromal cells. After exposure to 10 ng/mL recombinant human TGF-β1 (100-21, PeproTech, USA), which was the recommended dose for fibrosisrelated inducement [27] , EdSCs increased expression of COL1A1, ACTA2, CTGF, and FN1 (Fibronectin 1) in a time-dependent manner as detected by RT-qPCR ( Figure 6A ). Moreover, protein expression of fibrotic markers such as COL1A1, CTGF, ACTA2, and MMP2 incrementally increased in a time-dependent manner ( Figure 6B ). Additionally, components of the TGF-β1/Smad pathway, p-SMAD2, and p-SMAD3 were positively expressed and increased at the beginning time after TGF-β1 treatment ( Figure 6C ), then their expression decreased in a time-dependent manner. After TGF-β1 treatment, the expression of SMAD2 and SMAD3 gradually reduced. These results demonstrated that TGF-β1 plays a pivotal role in the development of EdSCs fibrosis in vitro and TGF-β1/Smad pathway was involved in this process.
Transforming growth factor β1/Smad pathway expression in the cystic walls of endometriomas
To determine whether the main components of TGF-β1/Smad signaling pathway was included in the cystic walls of endometriomas, a representative series of sections from cystic wall samples were evaluated through Masson's trichrome staining and specific IHC. As contrasted by negative control (Supplemental Figure S3E and F), positive IHC staining for TGFB1, TGFBR1, ACTA2, COL1A1, and CTGF ( Figure 7B-F) were found at the same regions as the fibrotic Masson's trichrome staining ( Figure 7A) . Interestingly, the result demonstrated the percentage of positive expression coverage areas were not significantly different among slides stained with TGFB1, TGFBR1, COL1A1, ACTA2, CTGF, p-SMAD2, p-SMAD3, SMAD2/3, SMAD2, SMAD3, and SMAD4 ( Figure 7M ). Moreover, these proteins were specifically expressed in the cystic walls and endometriotic loci. The magnifying images of the blue-square frames were correspondingly shown in Supplemental Figure S4A -L. The negative control was shown in Supplemental Figure S3E and F. These results demonstrated that the regions stained positive for fibrotic factors and TGFB1, TGFBR1 were the same sites where endometriotic cells proliferated.
Discussion
This study gives a light on the mechanism how endometriomas become more adherent to ovarian tissues compared with other benign ovarian cysts such as mature teratomas. The major findings are: (1) the cystic walls of endometriomas exhibited obvious fibrosis compared with mature teratomas, (2) endometriotic cells synthesized TGF-β1, a critical factor that promotes fibrosis formation, and (3) TGF-β1/Smad signaling contributed to the surrounding ovarian tissue fibrosis and adhesion. These findings demonstrate that endometriotic cells synthesize TGF-β1, facilitating fibrosis around the endometriomas, which results in damage to adjacent ovarian tissue, and TGF-β1/Smad signaling pathway was involved in this pathological process. Fibrosis is associated with the unbalanced synthesis and degradation of extracellular matrix (ECM), which is under the combined regulation of MMPs and TIMPs, resulting in an ongoing loss of normal tissue structure [28, 29] . Binding of TGF-β1 to TGFβR1 triggers signals mediated by the phosphorylation and activation of Smad2 and Smad3. Smad4 then binds activated Smad2/3, which enables this complex to translocate to the nucleus and transcribe specific genes [28] . Obvious fibrosis and highly expressed fibrotic factors, such as, COL1A1, ACTA2, and CTGF, were confirmed in endometriomas' cystic walls when compared to mature teratomas'. The expression of TIMP1 and MMP2 in the endometriotic cystic walls indicated the active synthesis and degradation of ECM. Our results agree with studies that showed fibrosis occurring around the endometriotic foci [30, 31] and explained why the resection rate of normal ovarian tissue in cystectomy specimen of endometriomas was significantly higher than the non-endometriotic cyst [32] . Studies showed that for endometriomas, the cortex of ovarian was associated with reduced follicular number and activity, while for teratomas or benign cystadenomas, the ovarian cortex was stretched and thinned without pathologically altering [33] . Brosens et al. reported that the presence of an endometrioma demonstrated progressive fibrosis of the cortical layer and detrimental impact on the ovarian follicle reserve, which was not correlated with the size of the endometrial cyst [34] . These reports indicated some certain factors related to endometriomas that played a critical role in the surrounding ovarian tissue fibrosis and eventually reduced ovarian reserve.
In women with endometriosis, TGF-β1 activity was increased at disease sites [35] , and peritoneal sites adjacent to lesions express higher levels of TGF-β1 than distal sites [36] . TGF-β could be detected at various stages in the peritoneal fluid of women with endometriosis, and its levels were concomitantly increased with disease severity [37] . Patients with stage III and IV endometriosis had much higher levels of TGF-β1 before treatment compared with patients with stage I or II disease [38] . Similarly, in a rat endometriosis model, TGF-β1 was induced by endometrial implants, which suggests a possible paracrine/autocrine role for TGF-β1 in the maintenance of viable endometriotic cells and the development of fibrous adhesions associated with the implants [39] .
In this study, we found TGFB1 expression exactly coincided with endometriotic cells in the cystic walls of endometriomas. Meanwhile, in mature teratomas, TGFB1 was not expressed in epithelial cells close to the cystic wall nor the cystic wall itself. Combining with the report that the endometriotic tissue penetrated into the endometrioma cystic wall in 100% of the cases [40] , we concluded that TGF-β1 expressed in all cases of endometriomas cystic walls. Moreover, western blot analysis testified that total TGFB1 protein expression in the endometriomas' cystic walls was significantly higher than mature teratomas. These findings indicate that TGF-β1 is specialized expressed in the cystic walls of endometriomas rather than mature teratomas, which can be regarded to be one of the potential reasons why dense fibrosis formed around endometriomas.
Furthermore, in this study, when EdSCs were exposed to TGF-β1, the mRNA and protein expression of fibrotic factors, such as COL1A1, ACTA2, MMP2, and CTGF, were promoted, which proved the vital role of TGF-β1 in fibrosis. On the other hand, FISH detection of TGFB1 on the cystic walls demonstrated it was endometriotic cells that synthesizing TGFB1 mRNA. Taken together, we hypothesis that the active endometriotic cells planted on ovary continuously synthesize and secrete TGF-β1, which promote surrounding ovarian tissue fibrosis and eventually cause severe adhesion around.
Smads operate downstream of TGF-β1 ligands [41, 42] . Activated Smad2 and Smad3 play distinct roles in collagen expression and tissue fibrosis [43] . This study verified that activated TGF-β1/Smad signaling by TGF-β1 treatment in vitro was associated with the expression of fibrosis-related genes in EdSCs. Serial sections of endometriotic cystic walls showed the regions of TGFB1 and TGFBR1 expression were identical to the endometriotic tissue where the fibrotic markers were expressed. Furthermore, the key components of this pathway, such as Smad2, p-Smad2, Smad3, p-Smad3, Smad2/3, and Smad4 were positive in the endometriotic cystic wall, which indicated that TGF-β1/Smad signaling was continuously expressed in the cystic wall of endometriomas. Coincidently, the TGF-β1/Smad signaling pathway was also found to be active in the peritoneum of patients with endometriosis [36] , suggesting that the expression of the pathway plays an important role in the development of endometriosis, and fibrosis [44] , which is closely related to adhesion formation [45] .
Researchers were dedicated to find a solution for the treatment of fibrosis targeting TGF-β1. Ren et al. reported that Dalbergioidin could ameliorate doxorubicin-induced renal fibrosis by suppressing the TGF-β signal pathway [46] . Zhang et al. found that miR18a-5p inhibited sub-pleural pulmonary fibrosis by targeting TGF-β receptor II [47] . Matsuzaki et al. studied that epigallocatechin-3-gallate have anti-fibrotic properties in endometriosis, which significantly inhibited TGF-β1-induced phosphorylation of Smad2/3 in both endometrial and endometriotic stromal cells [48] . As TGF-β1 expressed excessively in endometriosis and peritoneal fibrous adhesions, site-specific inhibition of TGF-β using antisense strategy was reported to be a useful tool for management of these lesions [49] . These studies hint that TGF-β1-targeting strategies might be useful in charge of the fibrosis formed around endometriotic loci.
Taken together, since endometriotic tissue starts planting in ovary, TGF-β1 gets continuously synthesized and secreted, which promotes surrounding ovarian tissue fibrosis and adhesion, eventually makes the cystectomy surgery difficult and loss ovarian tissue inadvertently. Early diagnosis and complete surgical removal of the endometriotic foci are suggested in order to protect the preservation of ovarian tissue. Whether the expression TGF-β1/Smad signaling pathway or the fibrotic micro-environment has a detrimental effect on the follicular density or oocyte quality in the ovary with endometriomas need to be further studied. And TGF-β1-targeting strategies on prevention and treatment of the fibrosis around endometriomas are worthy to be explored.
Conclusions
Endometriotic cells of endometriomas synthesize and secrete TGF-β1, which accumulates in the surrounding ovarian tissue, disorganizing ECM and promoting fibrosis, eventually forming fibrosis and adhesion to adjacent ovarian tissue. TGF-β1/Smad signaling pathway is involved in this pathological process. Owing to the adhesion to the ovarian tissue, excessively excision of the cystic wall can remove ovarian tissue, which can further damage the ovarian structure and decrease ovarian reserve. Therefore, blocking the pathological TGF-β1 expression that triggers fibrosis formation in the surrounding ovarian tissue would be of great importance for ovarian preservation.
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